Ads
related to: drug companies- For HCPs
Find Healthcare Professional
Resources & Information
- $0 Co-Pay
Learn How You Can Save on cGVHD
Treatment w/ our Co-Pay Program.
- For Chronic GVHD
Discover an Option That
May Help with Scarring and Swelling
- FAQs and Resources
Find Resources and Answers
to Frequently Asked Questions.
- For HCPs
opvee.com has been visited by 10K+ users in the past month
Search results
Highmark Members Save Significant Money on Outpatient Cancer Drug Available through CivicaScript
PRWeb· 8 hours ago"In 2020, Highmark teamed with the Blue Cross Blue Shield Association and other leading Blues health plans from across the U.S. to found CivicaScript, a nonprofit generic drug
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 8 hours agoIt agreed to pay $1.3 billion in cash and another $1.7 billion in future milestone-based payments...
Insmed shares skyrocket on positive trial results for lung drug By Proactive Investors
Investing.com· 1 day agoThe company said patients in the study with non-cystic fibrosis bronchiectasis who were dosed with...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar via Yahoo News· 2 days agoHealthcare. Almost a dozen pharmaceutical companies, including several major players, have lost...
AXIM Biotechnologies Receives Medical Device Manufacturing License
NewMediaWire via Yahoo Finance· 7 hours agoState of California Department of Public Heath Food and Drug Branch Issues the Company a License for...
From the Greeks to GLP-1s: The Complete History of Weight Loss Drugs
MediaFeed via AOL· 8 hours agoHumans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 8 hours agoJ&J is studying the drug, called seltorexant, as an “adjunctive” therapy to background treatment...
Ro launches GLP-1 tracker amid ongoing shortage
Crain's New York Business· 6 hours agoRo said its tracker may be an alternative to relying on the FDA's drug shortage list, as that list only includes drugs by active ingredient and not brand name. The FDA's list ...
Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
Pharmaceutical Technology via Yahoo Finance· 7 hours agoEnsifentrine is a first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor administered as a...
RFK Jr super PAC chair is publishing a tell-all memoir by Hunter Biden’s baby mama
The Independent via Yahoo News· 21 minutes agoThe company has published several books by Mr Kennedy pushing conspiracy theories regarding public...
